Structure-based virtual screening identified novel FOXM1 inhibitors as the lead compounds for ovarian cancer
Ovarian cancer (OC) is a gynecological tumor with possibly the worst prognosis, its 5-year survival rate being only 47.4%. The first line of therapy prescribed is chemotherapy consisting of platinum and paclitaxel. The primary reason for treatment failure is drug resistance. FOXM1 protein has been f...
Na minha lista:
| Principais autores: | , , , , , |
|---|---|
| Formato: | Artigo |
| Idioma: | Inglês |
| Publicado em: |
Frontiers Media S.A.
2022-11-01
|
| coleção: | Frontiers in Chemistry |
| Assuntos: | |
| Acesso em linha: | https://www.frontiersin.org/articles/10.3389/fchem.2022.1058256/full |
| Tags: |
Sem tags, seja o primeiro a adicionar uma tag!
|